Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure.

Elisabetta De Tommasi, Massimo Iacoviello, Roberta Romito, Claudio Ceconi, Pietro Guida, Francesco Massari, Gloria Francolini, Federico Bertocchi, Roberto Ferrari, Paolo Rizzon, Maria Vittoria Pitzalis

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

BACKGROUND: In chronic heart failure (CHF), the derangement of autonomic nervous system activity has a deep impact on the progression of the disease. It has been demonstrated that modulation of the renin-angiotensin aldosterone system (RAAS) increases autonomic control of heart rate and reduces adrenergic activity. We sought to evaluate, in CHF, the different effects of an ACE inhibitor (lisinopril) and of an AT1 receptor antagonist (valsartan) on heart rate variability, baroreflex sensitivity and norepinephrine plasma levels. METHODS: Ninety patients (61 +/- 10 years, 2.3 +/- 0.5, New York Heart Association class) with CHF and left ventricular ejection fraction

Original languageEnglish
JournalAmerican Heart Journal
Volume146
Issue number5
Publication statusPublished - Nov 2003

Fingerprint

Valsartan
Lisinopril
Autonomic Nervous System
Heart Failure
Heart Rate
Baroreflex
Renin-Angiotensin System
Angiotensin-Converting Enzyme Inhibitors
Stroke Volume
Adrenergic Agents
Disease Progression
Norepinephrine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

De Tommasi, E., Iacoviello, M., Romito, R., Ceconi, C., Guida, P., Massari, F., ... Pitzalis, M. V. (2003). Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. American Heart Journal, 146(5).

Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. / De Tommasi, Elisabetta; Iacoviello, Massimo; Romito, Roberta; Ceconi, Claudio; Guida, Pietro; Massari, Francesco; Francolini, Gloria; Bertocchi, Federico; Ferrari, Roberto; Rizzon, Paolo; Pitzalis, Maria Vittoria.

In: American Heart Journal, Vol. 146, No. 5, 11.2003.

Research output: Contribution to journalArticle

De Tommasi, E, Iacoviello, M, Romito, R, Ceconi, C, Guida, P, Massari, F, Francolini, G, Bertocchi, F, Ferrari, R, Rizzon, P & Pitzalis, MV 2003, 'Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure.', American Heart Journal, vol. 146, no. 5.
De Tommasi E, Iacoviello M, Romito R, Ceconi C, Guida P, Massari F et al. Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. American Heart Journal. 2003 Nov;146(5).
De Tommasi, Elisabetta ; Iacoviello, Massimo ; Romito, Roberta ; Ceconi, Claudio ; Guida, Pietro ; Massari, Francesco ; Francolini, Gloria ; Bertocchi, Federico ; Ferrari, Roberto ; Rizzon, Paolo ; Pitzalis, Maria Vittoria. / Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. In: American Heart Journal. 2003 ; Vol. 146, No. 5.
@article{a4f6eedb4eba4d4f94fc2f7d875fe26d,
title = "Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure.",
abstract = "BACKGROUND: In chronic heart failure (CHF), the derangement of autonomic nervous system activity has a deep impact on the progression of the disease. It has been demonstrated that modulation of the renin-angiotensin aldosterone system (RAAS) increases autonomic control of heart rate and reduces adrenergic activity. We sought to evaluate, in CHF, the different effects of an ACE inhibitor (lisinopril) and of an AT1 receptor antagonist (valsartan) on heart rate variability, baroreflex sensitivity and norepinephrine plasma levels. METHODS: Ninety patients (61 +/- 10 years, 2.3 +/- 0.5, New York Heart Association class) with CHF and left ventricular ejection fraction",
author = "{De Tommasi}, Elisabetta and Massimo Iacoviello and Roberta Romito and Claudio Ceconi and Pietro Guida and Francesco Massari and Gloria Francolini and Federico Bertocchi and Roberto Ferrari and Paolo Rizzon and Pitzalis, {Maria Vittoria}",
year = "2003",
month = "11",
language = "English",
volume = "146",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure.

AU - De Tommasi, Elisabetta

AU - Iacoviello, Massimo

AU - Romito, Roberta

AU - Ceconi, Claudio

AU - Guida, Pietro

AU - Massari, Francesco

AU - Francolini, Gloria

AU - Bertocchi, Federico

AU - Ferrari, Roberto

AU - Rizzon, Paolo

AU - Pitzalis, Maria Vittoria

PY - 2003/11

Y1 - 2003/11

N2 - BACKGROUND: In chronic heart failure (CHF), the derangement of autonomic nervous system activity has a deep impact on the progression of the disease. It has been demonstrated that modulation of the renin-angiotensin aldosterone system (RAAS) increases autonomic control of heart rate and reduces adrenergic activity. We sought to evaluate, in CHF, the different effects of an ACE inhibitor (lisinopril) and of an AT1 receptor antagonist (valsartan) on heart rate variability, baroreflex sensitivity and norepinephrine plasma levels. METHODS: Ninety patients (61 +/- 10 years, 2.3 +/- 0.5, New York Heart Association class) with CHF and left ventricular ejection fraction

AB - BACKGROUND: In chronic heart failure (CHF), the derangement of autonomic nervous system activity has a deep impact on the progression of the disease. It has been demonstrated that modulation of the renin-angiotensin aldosterone system (RAAS) increases autonomic control of heart rate and reduces adrenergic activity. We sought to evaluate, in CHF, the different effects of an ACE inhibitor (lisinopril) and of an AT1 receptor antagonist (valsartan) on heart rate variability, baroreflex sensitivity and norepinephrine plasma levels. METHODS: Ninety patients (61 +/- 10 years, 2.3 +/- 0.5, New York Heart Association class) with CHF and left ventricular ejection fraction

UR - http://www.scopus.com/inward/record.url?scp=1542496392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542496392&partnerID=8YFLogxK

M3 - Article

C2 - 14597946

AN - SCOPUS:1542496392

VL - 146

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 5

ER -